Compare DexCom, Inc. (DXCM) vs General Dynamics Corporation (GD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs General Dynamics Corporation — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while General Dynamics Corporation trades at $391.11 (market cap $106.03B). The key difference: General Dynamics Corporation is far larger — about 3.1× DexCom, Inc.'s market cap, and General Dynamics Corporation pays a 1.62% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | GD | |
|---|---|---|
Market Cap | $33.79B | $106.03B |
Sector | Health | Industrials |
52-Week High | $89.53 | $395.97 |
52-Week Low | $54.84 | $312.53 |
Enterprise Value | $33.24B | $111.17B |
Dividend Yield | — | 1.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About General Dynamics Corporation
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →
